Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 years and Older With and Without Atopic Comorbidities. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s322. https://doi.org/10.25251/skin.8.supp.322